Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system

被引:116
作者
Laczy, Boglarka [1 ]
Hill, Bradford G. [2 ,3 ]
Wang, Kai [4 ]
Paterson, Andrew J. [4 ]
White, C. Roger [1 ,3 ,5 ]
Xing, Dongqi [1 ,6 ]
Chen, Yiu-Fai [1 ,6 ]
Darley-Usmar, Victor [2 ,5 ,6 ]
Oparil, Suzanne [1 ,3 ,5 ,6 ]
Chatham, John C. [1 ,3 ,5 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA
[5] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL 35294 USA
[6] Univ Alabama Birmingham, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2009年 / 296卷 / 01期
基金
美国国家卫生研究院;
关键词
hexosamine biosynthesis; protein O-glycosylation; beta-N-acetylglucosamine transferase; diabetes mellitus; LINKED N-ACETYLGLUCOSAMINE; HUMAN GLUTAMINE-FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE; ISCHEMIA-REPERFUSION INJURY; CAPACITATIVE CALCIUM-ENTRY; INHIBITOR-1 GENE PROMOTER; ENDOTHELIAL GROWTH-FACTOR; IMPAIRED SERCA FUNCTION; BETA-D-GLUCOSAMINIDASE; NITRIC-OXIDE SYNTHASE; MUTATIONAL HOT-SPOT;
D O I
10.1152/ajpheart.01056.2008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Laczy B, Hill BG, Wang K, Paterson AJ, White CR, Xing D, Chen Y, Darley-Usmar V, Oparil S, Chatham JC. Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system. Am J Physiol Heart Circ Physiol 296: H13-H28, 2009. First published November 21, 2008; doi: 10.1152/ajpheart.01056.2008. - The posttranslational modification of serine and threonine residues of nuclear and cytoplasmic proteins by the O-linked attachment of the monosaccharide beta-N-acetylglucosamine (O-GlcNAc) is a highly dynamic and ubiquitous protein modification. Protein O-GlcNAcylation is rapidly emerging as a key regulator of critical biological processes including nuclear transport, translation and transcription, signal transduction, cytoskeletal reorganization, proteasomal degradation, and apoptosis. Increased levels of O-GlcNAc have been implicated as a pathogenic contributor to glucose toxicity and insulin resistance, which are both major hallmarks of diabetes mellitus and diabetes-related cardiovascular complications. Conversely, there is a growing body of data demonstrating that the acute activation of O-GlcNAc levels is an endogenous stress response designed to enhance cell survival. Reports on the effect of altered O-GlcNAc levels on the heart and cardiovascular system have been growing rapidly over the past few years and have implicated a role for O-GlcNAc in contributing to the adverse effects of diabetes on cardiovascular function as well as mediating the response to ischemic injury. Here, we summarize our present understanding of protein O-GlcNAcylation and its effect on the regulation of cardiovascular function. We examine the pathways regulating protein O-GlcNAcylation and discuss, in more detail, our understanding of the role of O-GlcNAc in both mediating the adverse effects of diabetes as well as its role in mediating cellular protective mechanisms in the cardiovascular system. In addition, we also explore the parallels between O-GlcNAc signaling and redox signaling, as an alternative paradigm for understanding the role of O-GlcNAcylation in regulating cell function.
引用
收藏
页码:H13 / H28
页数:16
相关论文
共 235 条
[1]   Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats [J].
Abe, T ;
Ohga, Y ;
Tabayashi, N ;
Kobayashi, S ;
Sakata, S ;
Misawa, H ;
Tsuji, T ;
Kohzuki, H ;
Suga, H ;
Taniguchi, S ;
Takaki, M .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 282 (01) :H138-H148
[2]   Advanced glycation endproducts: what is their relevance to diabetic complications? [J].
Ahmed, N. ;
Thornalley, P. J. .
DIABETES OBESITY & METABOLISM, 2007, 9 (03) :233-245
[3]   Role of changes in cardiac metabolism in development of diabetic cardiomyopathy [J].
An, Ding ;
Rodrigues, Brian .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (04) :H1489-H1506
[4]   Cellular and molecular determinants of altered Ca2+ handling in the failing rabbit heart:: primary defects in SR Ca2+ uptake and release mechanisms [J].
Armoundas, Antonis A. ;
Rose, Jochen ;
Aggarwal, Rajesh ;
Stuyvers, Bruno D. ;
O'Rourke, Brian ;
Kass, David A. ;
Marban, Eduardo ;
Shorofsky, Stephen R. ;
Tomaselli, Gordon F. ;
Balke, C. William .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2007, 292 (03) :H1607-H1618
[5]   The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy [J].
Asbun, J ;
Villarreal, FJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) :693-700
[6]   Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin E [J].
Asbun, J ;
Manso, AM ;
Villarreal, FJ .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 288 (01) :H227-H234
[7]   SiRNA-mediated reduction of inhibitor of nuclear factor-κB kinase prevents tumor necrosis factor-α-induced insulin resistance in human skeletal muscle [J].
Austin, Reginald L. ;
Rune, Anna ;
Bouzakri, Karim ;
Zierath, Juleen R. ;
Krook, Anna .
DIABETES, 2008, 57 (08) :2066-2073
[8]   Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart [J].
Belke, DD ;
Swanson, EA ;
Dillmann, WH .
DIABETES, 2004, 53 (12) :3201-3208
[9]   Diabetic cardiomyopathy [J].
Bell, DSH .
DIABETES CARE, 2003, 26 (10) :2949-2951
[10]   Evidence for genetic linkage of Alzheimer's disease to chromosome 10q [J].
Bertram, L ;
Blacker, D ;
Mullin, K ;
Keeney, D ;
Jones, J ;
Basu, S ;
Yhu, S ;
McInnis, MG ;
Go, RCP ;
Vekrellis, K ;
Selkoe, DJ ;
Saunders, AJ ;
Tanzi, RE .
SCIENCE, 2000, 290 (5500) :2302-+